Transcriptomic profiling facilitates classification of response to influenza challenge. by Davenport, E, Antrobus, R, Lillie, P, Gilbert, S, Knight, J

Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting. by Lillie, P, Andrews, D, Eaves, K, Darton, T, Chapman, A

Distinguishing malaria and influenza: early clinical features in controlled human experimental infection studies. by Lillie, P, Duncan, C, Sheehy, S, Meyer, J, O'Hara, G, Gilbert, S, Hill, A

Distinguishing malaria and influenza: Early clinical features in controlled human experimental infection studies by Lillie, P, Duncan, C, Sheehy, S, Meyer, J, O'Hara, G, Gilbert, S, Hill, A

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine by Powell, T, Peng, Y, Berthoud, T, Blais, M, Lillie, P, Hill, A, Rowland-Jones, S, McMichael, A, Gilbert, S, Dong, T

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years. by Antrobus, R, Lillie, P, Berthoud, T, Spencer, A, McLaren, J, Ladell, K, Lambe, T, Milicic, A, Price, D, Hill, A, Gilbert, S

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. by Berthoud, T, Hamill, M, Lillie, P, Hwenda, L, Collins, K, Ewer, K, Milicic, A, Poyntz, H, Lambe, T, Fletcher, H, Hill, A, Gilbert, S

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults by Harris, S, Meyer, J, Satti, I, Kostov, M, Rowland, R, Poulton, I, Poyntz, H, Tanner, R, Lillie, P, Lawrie, A, Hill, A, Mcshane, H

Incidental Diagnosis in Healthy Clinical Trial Subjects by Duncan, C, Rowland, R, Lillie, P, Meyer, J, Sheehy, S, O'Hara, G, Hamill, M, Donaldson, H, Dinsmore, L, Poulton, I, Gilbert, S, Mcshane, H, Hill, A

Incidental diagnosis in healthy clinical trial subjects. by Duncan, C, Rowland, R, Lillie, P, Meyer, J, Sheehy, S, O'Hara, G, Hamill, M, Donaldson, H, Dinsmore, L, Poulton, I, Gilbert, S, Mcshane, H, Hill, A

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans. by Lillie, P, Berthoud, T, Powell, T, Lambe, T, Mullarkey, C, Spencer, A, Hamill, M, Peng, Y, Blais, M, Duncan, C, Sheehy, S, Havelock, T, Faust, S, Williams, R, Gilbert, A, Oxford, J, Dong, T, Hill, A, Gilbert, S

SAFETY, IMMUNOGENICITY AND IMPACT ON PARASITE MULTIPLICATION RATES OF THE CANDIDATE BLOOD-STAGE VACCINE AMA1-C1/ALHYDROGEL WITH THE NOVEL ADJUVANT CPG 7909 AGAINST BLOOD-STAGE MALA... by Duncan, C, Sheehy, S, Ewer, K, Douglas, A, Halstead, F, Edwards, N, Collins, K, Lillie, P, Poulton, I, Hunt-Cooke, A, Lawrie, A, Draper, S, Gilbert, S, Fay, M, Miura, K, Long, C, Wu, Y, Hill, A, Ellis, R

HETEROLOGOUS PRIME-BOOST VACCINATION WITH ADCH63 AND MVA EXPRESSING MSP1 CAN INDUCE PROTECTIVE EFFICACY AGAINST SPOROZOITE CHALLENGE IN VOLUNTEERS by Sheehy, S, Duncan, C, Elias, S, Collins, K, Ewer, K, Edwards, N, Blagborough, A, Sinden, R, Murphy, J, Correa, S, Hunt-Cooke, A, Meyer, J, Lillie, P, Colloca, S, Cortese, R, Nicosia, A, Poulton, I, Long, C, Gilbert, S, Lawrie, A, Hill, A, Draper, S

ChAd63-MVA-vectored blood-stage Malaria vaccines targeting MSP1 and AMA1: Assessment of efficacy against mosquito bite challenge in humans by Sheehy, S, Duncan, C, Elias, S, Choudhary, P, Biswas, S, Halstead, F, Collins, K, Edwards, N, Douglas, A, Anagnostou, N, Ewer, K, Havelock, T, Havelock, T, Mahungu, T, Bliss, C, Miura, K, Poulton, I, Lillie, P, Antrobus, R, Berrie, E, Moyle, S, Gantlett, K, Colloca, S, Colloca, S, Cortese, R

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. by Sheehy, S, Duncan, C, Elias, S, Choudhary, P, Biswas, S, Halstead, F, Collins, K, Edwards, N, Douglas, A, Anagnostou, N, Ewer, K, Havelock, T, Mahungu, T, Bliss, C, Miura, K, Poulton, I, Lillie, P, Antrobus, R, Berrie, E, Moyle, S, Gantlett, K, Colloca, S, Cortese, R, Long, C, Sinden, R

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. by Duncan, C, Sheehy, S, Ewer, K, Douglas, A, Collins, K, Halstead, F, Elias, S, Lillie, P, Rausch, K, Aebig, J, Miura, K, Edwards, N, Poulton, I, Hunt-Cooke, A, Porter, D, Thompson, F, Rowland, R, Draper, S, Gilbert, S, Fay, M, Long, C, Zhu, D, Wu, Y, Martin, L, Anderson, C, Lawrie, A, Hill, A, Ellis, R